Announced Thu, 9 Jul · 15:42 IST
Routine compliance filing: RTA certificate for Q1 under SEBI Regulation 74(5)
Compliance View source PDF
SANOFICONR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.9%1-day move
₹4508.00
prior close
₹4529.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
—+0.2——+1.9+1.4+0.4+2.0+1.0+2.2————
Up moveDown movePending
AI summary
Sanofi Consumer Healthcare India submitted a routine quarterly certificate to the stock exchanges. The certificate, issued by its Registrar and Share Transfer Agent MUFG Intime India, confirms that securities received for dematerialisation during the quarter ended 30 June 2026 were processed, listed and reflected in the register of members as required under SEBI Regulation 74(5). This is a standard procedural filing with no business or financial implication.
Likely market impact
No material impact. This is a routine quarterly regulatory compliance submission with no effect on business or shareholders.